Back

One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

2 September 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Insights from acute coronary syndrome registries Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

5 More presentations in this session

Presentation thumbnail
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
Doctor F. Marin (Murcia, ES)
Abstract
Presentation thumbnail
Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis
Professor D. Sibbing (Munich, DE)
Abstract Slides
Presentation thumbnail
Ischemic-bleeding balance according to history of prior bleeding in patients with acute coronary syndrome during treatment with dual antiplatelet therapy
Ms B. Caneiro-Queija (Vigo, ES)
Abstract Slides
Presentation thumbnail
Percutaneous coronary intervention in the age of frailty
Doctor M. Bergami (Bologna, IT)
Abstract Slides
Presentation thumbnail
Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden
Mr K. Kintis (Athens, GR)

Access the full session

Session thumbnail
Insights from acute coronary syndrome registries

The Event

Event poster

ESC Congress 2019

2 September 2019 12:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources